US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Sinovac Biotech Ltd (SVA)
Sinovac Biotech Ltd (SVA) ニュース

SVA

Sinovac Biotech (SVA)

Sinovac Biotech Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SVA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/30	06 : 53	Business Wire	SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F	NASDAQ:SVA	Sinovac Biotech Ltd
2024/02/21	20 : 09	Edgar (US Regulatory)	Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2024/02/21	20 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SVA	Sinovac Biotech Ltd
2024/02/21	16 : 56	Business Wire	Sinovac Amends Shareholder Rights Plan	NASDAQ:SVA	Sinovac Biotech Ltd
2024/02/03	01 : 19	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/19	20 : 58	Business Wire	シノバック取締役会、一方的な部分公開買い付けを全会一致で退ける	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/19	04 : 54	Business Wire	Sinovac董事會一致反對Alternative Liquidity主動提出的部分公開收購方案	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/19	04 : 47	Business Wire	Le conseil d'administration de Sinovac rejette à l'unanimité une offre partielle non sollicitée	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/19	03 : 33	Business Wire	Das Board of Directors von Sinovac lehnt einstimmig ein unaufgefordert abgegebenes Teilkaufangebot ab	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/18	21 : 13	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/18	21 : 00	Business Wire	Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/09	06 : 46	Edgar (US Regulatory)	Form SC TO-T - Tender offer statement by Third Party	NASDAQ:SVA	Sinovac Biotech Ltd
2023/12/04	20 : 01	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2023/10/03	22 : 39	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/15	21 : 59	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/12	19 : 10	Business Wire	シノバック、新型コロナウイルスに対するSA55抗体注射剤の臨床試験について進展を報告	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/11	23 : 36	Business Wire	SINOVAC rend compte des progrès réalisés dans le cadre de son essai clinique concernant l’injection anti-COVID-19 à base d’anticorps SA55	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/11	23 : 36	Business Wire	SINOVAC informiert über die Fortschritte bei der klinischen Studie für den Anti-COVID-19-Antikörper SA55 Injection	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/11	19 : 16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/11	18 : 55	Business Wire	SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/06	20 : 35	Business Wire	シノバック取締役会、同意なき株式の部分公開買付を全会一致で拒否	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/06	01 : 16	Business Wire	Sinovac-Vorstand lehnt ein unangefordertes Teilübernahmeangebot einstimmig ab	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/06	00 : 36	Business Wire	Le conseil d’administration de Sinovac rejette à l’unanimité une offre publique d’achat partielle non sollicitée	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/05	20 : 04	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/05	17 : 12	Business Wire	Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer	NASDAQ:SVA	Sinovac Biotech Ltd
2023/08/30	02 : 08	Business Wire	シノバック、部分的な株式公開買付を一方的に受けたことを確認	NASDAQ:SVA	Sinovac Biotech Ltd
2023/08/29	22 : 04	Business Wire	Sinovac bestätigt den Erhalt eines unangeforderten Teilübernahmeangebots	NASDAQ:SVA	Sinovac Biotech Ltd
2023/08/29	19 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SVA	Sinovac Biotech Ltd
2023/08/29	19 : 05	Business Wire	Sinovac confirme la réception d'une offre publique d’achat partielle non sollicitée	NASDAQ:SVA	Sinovac Biotech Ltd
2023/08/29	16 : 07	Business Wire	Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer	NASDAQ:SVA	Sinovac Biotech Ltd

Showing the most relevant articles for your search:NASDAQ:SVA

1 2 3 4 5 6 7 8 9 10 次へ >>

JP Morgan Chase

Health Care Select Sector

Financial Select Sector

American Express

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約